If the Exploitation of a Licensed Product in the Territory pursuant to this Agreement results in, or is reasonably expected to result in, any claim, suit or proceeding by a Third Party alleging infringement by Allergan or any of its Affiliates or its or their Sublicensees, distributors or customers (a “ Third Party Infringement Claim ”), including any defense or counterclaim in connection with an infringement action initiated pursuant to Section 9.1, the Party first becoming aware of such alleged infringement shall promptly notify the other Party thereof in writing.